BMEDvsFXHETF Comparison
VS
iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. First Trust Health Care AlphaDEX Fund ETF (FXH) is part of the US Health Care segment. BMED's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, FXH's top sector exposures are Healthcare. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.61% for FXH. BMED is up 12.35% year-to-date (YTD) with +$5M in YTD flows. FXH performs better with 17.11% YTD performance, and +$59M in YTD flows. Run a side-by-side ETF comparison of BMED and FXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BMED vs FXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/01/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED FXH | +9.94%+4.59% | +19.78%+16.13% | +12.35%+17.11% | +29.36%+23.46% | +41.24%+30.25% | +10.84%+7.96% |
| Flows | BMED FXH | +$1M+$52M | +$1M+$131M | +$5M+$59M | +$7M+$37M | +$7M-$510M | +$6M-$437M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED FXH | +21.97%+16.57% | +17.43%+15.72% | +16.63%+15.60% | +18.01%+16.91% |
| Max drawdown | BMED FXH | -4.62%-3.81% | -14.71%-12.07% | -19.76%-17.66% | -33.96%-29.40% |
| Max drawdown duration | BMED FXH | 32d20d | 196d168d | 237d395d | 1586d1759d |
Trading data
BMED | FXH | |
Last sale 9/2/2026 at 1:30 PM | $34.28 | $134.22 |
| Previous close 09/01/2026 | $33.91 | $133.01 |
| Consolidated volume 09/01/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BMED
is actively managed and doesn’t replicate an indexBMED | FXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/2/2026 at 1:30 PM
Live
Closed
BMED | FXH | |
|---|---|---|
| Last price | $34.28 | $134.22 |
| 1D performance | +1.10% | +0.91% |
| AuM | $13.57 M | $1.15 B |
| E/R | 0.77% | 0.61% |
Characteristics
BMED | FXH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | iShares | First Trust |
| Benchmark | - | StrataQuant Health Care Index |
| N° of holdings | 53 | 72 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 29, 2020 | May 8, 2007 |
| ESG | No | No |
Advertisement
Exposure
Countries
BMED
USA
86.04%
Other
13.96%
FXH
USA
93.07%
Other
6.93%
Sectors
BMED
Healthcare
95.69%
Other
4.31%
FXH
Healthcare
98.24%
Other
1.76%
Diversification
BMED
Total weight of top 15 holdings out of 15
56.15%
FXH
Total weight of top 15 holdings out of 15
35.54%
Top 15 holdings
Data as of July 31, 2026
BMED
Merck & Co., Inc.
5.85%
Gilead Sciences, Inc.
4.87%
Johnson & Johnson
4.45%
Edwards Lifesciences Corp.
4.43%
Thermo Fisher Scientific, Inc.
4.17%
Charles River Laboratories International, Inc.
3.72%
Danaher Corp.
3.63%
Biogen, Inc.
3.58%
Waters Corp.
3.50%
AbbVie, Inc.
3.50%
Mettler-Toledo International, Inc.
3.37%
Moderna, Inc.
3.07%
Vertex Pharmaceuticals, Inc.
2.96%
BlackRock Cash Funds - Treasury
2.58%
Amgen, Inc.
2.49%
FXH
Regeneron Pharmaceuticals, Inc.
2.85%
Natera, Inc.
2.57%
Universal Health Services, Inc.
2.50%
Boston Scientific Corp.
2.49%
Pfizer Inc.
2.48%
Solventum Corp.
2.47%
Zimmer Biomet Holdings, Inc.
2.47%
Guardant Health, Inc.
2.41%
Tenet Healthcare Corp.
2.34%
Globus Medical, Inc.
2.33%
Corcept Therapeutics, Inc.
2.24%
Halozyme Therapeutics, Inc.
2.18%
Centene Corp.
2.15%
The Cigna Group
2.14%
Encompass Health Corp.
1.92%
Frequently asked questions about BMED and FXH
How have the BMED and FXH ETFs performed in 2026?
As of September 1, 2026, BMED is up 12.35% year-to-date (YTD), while FXH has returned 17.11%. That puts FXH better performer ahead so far this year.
Which ETF is attracting more investor money: BMED or FXH?
Year-to-date, the BMED ETF saw +$5M in flows, compared to +$59M for FXH.
Which ETF is more volatile: BMED or FXH?
Over the past year, BMED had a volatility of 17.43%, while FXH experienced 15.72%.
Which ETF is bigger: BMED or FXH?
As of September 1, 2026, BMED holds $13.57 M in assets under management (AUM), while FXH manages $1.15 B.
What sectors do the BMED and FXH ETFs invest in?
BMED leans toward sectors like Healthcare. Meanwhile, FXH focuses on Healthcare.
What are the top holdings of the BMED ETF and FXH ETF?
BMED top holdings include Merck & Co., Inc., Gilead Sciences, Inc. and Johnson & Johnson. FXH holds in its top three: Regeneron Pharmaceuticals, Inc., Natera, Inc. and Universal Health Services, Inc..
Which ETF is more diversified: BMED or FXH?
BMED holds 56 securities with 56.15% of its assets in the top 15. FXH has 72 securities and a top 15 weight of 35.54%.
Advertisement
Advertisement
